The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension

Despite knowledge regarding the importance of controlling patients' blood pressure (BP) only 30% of treated patients achieve BP goals. Our objective was to determine the effect of frequent self measurements of BP in the patients' natural environment as a mean to improve BP control. Our hypothesis was that frequent measurements of BP will reduce mean BP levels...

Date First Received: April 10, 2007

Last Updated: April 10, 2007

Verified by: Sheba Medical Center, April 2007

Clinical Trial Phase: Phase 3 | Start Date: December 2002

Overall Status: Completed

Estimated Enrollment: 150

Brief Summary

Official Title: “The Effect of Frequent Self Measurements of Blood Pressure on the Control of Hypertension”

Condition Keyword(s):

Despite knowledge regarding the importance of controlling patients' blood pressure (BP) only 30% of treated patients achieve BP goals. Our objective was to determine the effect of frequent self measurements of BP in the patients' natural environment as a mean to improve BP control. Our hypothesis was that frequent measurements of BP will reduce mean BP levels.

Study Type: Interventional

Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Intervention(s) in this Clinical Trial

  • Device: Portable blood pressure wrist manometer

Outcome Measures for this Clinical Trial

Primary Measures

  • Meam blood pressure

Secondary Measures

  • Satisfaction
  • Quality of life

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Signing an informed consent form
  • Having a diagnosis of hypertension for more than one year according to patients'records.
  • receiving at least one medication for hypertension
  • A reasonable understanding of Hebrew
  • An ambulatory state enabling regular visits to a primary physician in the community and self-measurement of hypertension using the electronic device

Exclusion Criteria:

  • Lack of willingness to participate in the study.Known arrhythmia
  • Malignant disease
  • Poor understanding of Hebrew

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: N/A

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Sponsor Information

Lead Sponsor: Sheba Medical Center

Overall Clinical Trial Officials and Contacts

Yasmin Maor, MD Principal Investigator Sheba Medical Center  

Additional Information

Information obtained from ClinicalTrials.gov on August 28, 2008

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00459017

Study ID Number: SHEBA -02-2773-YM-CTIL

ClinicalTrials.gov Identifier: NCT00459017

Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Clinical Trials Authorship and Review

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.